Radiation Biology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892-1002, USA.
Cancer Lett. 2010 Mar 1;289(1):119-26. doi: 10.1016/j.canlet.2009.08.009. Epub 2009 Aug 26.
Transforming growth factor beta (TGF-beta) is implicated in radiation-induced fibrosis of normal tissues in patients receiving radiotherapy. Inhibiting the TGF-beta signaling pathway by various means has been shown to reduce radiation-induced fibrosis in pre-clinical studies. The present study evaluated the effects of interfering with the TGF-beta signaling pathway on the radiosensitivity of selected human tumor cell lines using the plant-derived alkaloid, halofuginone. Halofuginone treatment inhibited cell growth, halted cell cycle progression, decreased radiation-induced DNA damage repair, and decreased TGF-beta receptor II protein levels, leading to increased cellular radiosensitization. These data further support the goal of manipulating the TGF-beta pathway to achieve a positive increase in the therapeutic gain in clinical radiotherapy.
转化生长因子-β(TGF-β)与接受放射治疗的患者正常组织的放射性纤维化有关。通过各种手段抑制 TGF-β信号通路已被证明可减少临床前研究中的放射性纤维化。本研究使用植物衍生的生物碱血根碱评估了干扰 TGF-β信号通路对选定的人类肿瘤细胞系放射敏感性的影响。血根碱处理抑制细胞生长、阻止细胞周期进程、减少辐射诱导的 DNA 损伤修复、降低 TGF-β受体 II 蛋白水平,导致细胞放射敏感性增加。这些数据进一步支持操纵 TGF-β途径以在临床放射治疗中实现治疗增益的积极增加的目标。